Note: Ingredients listed on restricted chemical lists
EC/CAS
58-46-8
Name of the chemical
Tetrabenazine (INN) and its salts
Concentration
100%
General Information
Revision date
2020-03-24
Product name
Tetrabenazine Tablets Head Office (Hyderabad) 12.5 mg
CAS No.
58-46-8
Manufacturer Name
Tetrabenazine Tablets Head Office (Hyderabad) 12.5 mg
Icons in SDS
Company Information
company name
Slate Run Pharmaceuticals, LLC
Section 2
SECTION 2: Hazards identification
Emergency telephone: Direct - +91-8451-287 531, 287 508. Mobile - +7032919766. E Mail: jagannath.S@piramal.com Fire and Explosion Expected to be non-combustible. Health Tetrabenazine is contraindicated in patients: Who are actively suicidal, or in patients with untreated or inadequately treated depression With hepatic impairment Taking monoamine oxidase inhibitors (MAOIs). Tetrabenazine should not be used in combination with an MAOI, or within a minimum of 14 days of discontinuing therapy with an MAOI Taking reserpine. At least 20 days should elapse after stopping reserpine before starting tetrabenazine Taking deutetrabenazine or valbenazine
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.